Instagram Outage Disrupts Thousands of U.S. Users 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
PLANO, Texas, March 27, 2017 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Cowen and Company and The Ruth Group are hosting a physician panel on the spinal cord stimulation market and the Algovita system. The event will feature discussions with Jeffery Rowe, MD, and Brian Bannister, MD, and will be moderated by Cowen medical technology analyst Josh Jennings, MD.
| Event: | Spinal Cord Stimulation Physician Panel |
| Date: | Wednesday, March 29, 2017 |
| Time: | 12:00 pm ET |
| Location: | Cowen and Company Offices; 599 Lexington Ave, New York |
A webcast of the event will be available by visiting the investor relations section of Nuvectra’s website at www.nuvectramed.com.
If interested in attending the live event please contact your Cowen sales representative or The Ruth Group.
Participating Physicians
Jeffery Rowe, MD is a practicing physician at Main Line Spine in King of Prussia Pennsylvania, a comprehensive care center for spine related conditions and injuries. Dr. Rowe attended medical school at Saba University School of Medicine. Upon completing medical school he entered a General Surgery residency at Medical College of Pennsylvania/Hahnemann University before beginning his Physical Medicine and Rehabilitation residency at University of Pennsylvania. Following residency he was fellowship trained in Interventional Spine and Pain Medicine. Dr. Rowe is board certified in Physical Medicine & Rehabilitation and in Pain Medicine. His professional interests include the management of complex pain related medical issues with minimally invasive injections through trial and surgically implanted spinal cord stimulators.
Brian Bannister, MD is a practicing physician at Progressive Pain Management in Monmouth County, NJ, where he takes a multimodal approaches to pain control using proven, innovative techniques, combined with compassionate and individualized care. Dr. Bannister attended medical school at the State University of New York, Upstate Medical University where he also completed a Fellowship in Pain Management and his residency in Clinical Anesthesiology. Dr. Bannister is board certified in Anesthesiology.
About Nuvectra Corporation
Nuvectra™ is a neurostimulation company committed to helping physicians improve the lives of people with chronic neurological conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation (DBS). In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at www.nuvectramed.com.
Company Contacts: Nuvectra Corporation Walter Berger, Chief Operating Officer and Chief Financial Officer (214) 474-3102 [email protected] Jennifer Armstrong, Media Relations (214) 474-3110 [email protected] Investor Contacts: The Ruth Group Nick Laudico (646) 536-7030 [email protected] Zack Kubow (646) 536-7020 [email protected]
